Making Medicines, from Laboratory to Pilot Plant Manufacture

Synopsis

The journey of a successful medicine from discovery through development, to the treatment of patients is a long and complex process. One crucial aspect of this is the manufacture of the active pharmaceutical ingredient (API), with ever increasing quantities required from initially grams for safety testing, up to potentially thousands of kilograms for a commercial marketed medicine.

This talk will provide a general overview of the development process. More detailed stories from the laboratory synthesis of potential medicines currently in the early stages of development, up to the large-scale manufacture of more advanced projects in a specialised Pilot Plant will also be shared. Focus and comparison on the changing technical, safety, accommodation and regulatory challenges during this journey will offer an engaging insight for all those interested in how medicines are made.

Speakers:
Dr James Douglas, AstraZeneca UK
Abi Thorne, AstraZeneca UK

Time: 18:00 for 18:30

Programme

Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.

Venue and Contact

Fees

Booking Process/Deadlines

Booking terms and conditions

CPD Info

SCI Members attending this meeting are able to claim CPD points.

Additional Info

Exhibition and Sponsorship

An exhibition will take place alongside the conference for companies and related organisations who may wish to exhibit. Please email conferences@soci.org for further information and prices. Spaces are limited and will be allocated on a first-come, first-served basis.